Title: Rational design and evaluation of new lead compound structures for selective betaARK1 inhibitors.
Journal: Journal of medicinal chemistry 20020523
17696-60-5
13036-19-6
588-53-4
24742-30-1
10484-13-6
836-41-9
58417-15-5 | 4-(DIFLUOROMETHOXY)PHENYL ISOCYANATE | AA003K4R | MFCD00673056
224309-64-2 | (4-Hydroxy-cyclohexyl)-carbamic acid tert-butyl ester | AA003K7P | MFCD06658349
92-88-6 | 4,4'-Dihydroxybiphenyl | AA003KBA | MFCD00002348
5788-58-9 | 4,5-Dibromopyridazin-3(2h)-one | AA003KEL | MFCD00023641
75867-39-9 | 4-((Trimethylsilyl)ethynyl)aniline | AA003KI0 | MFCD03695479
5628-44-4 | 4-Amino-2,3-dimethyl-benzoic acid | AA003KLC | MFCD04114099
680185-86-8 | 4-Amino-n-furan-2-yl-methylbenzamide | AA003KOQ | MFCD03425053
864845-15-8 | 4-Bromo-3-hydroxy (1h)indazole | AA003KS4 | MFCD13176950
56518-42-4 | 4-Bromo-3,5-dimethoxybenzoic acid | AA003KUZ | MFCD01632140
1967-25-5 | 4-BROMOPHENYLUREA | AA003KYB | MFCD00025428